econintersect.com
       
  

FREE NEWSLETTER: Econintersect sends a nightly newsletter highlighting news events of the day, and providing a summary of new articles posted on the website. Econintersect will not sell or pass your email address to others per our privacy policy. You can cancel this subscription at any time by selecting the unsubscribing link in the footer of each email.



posted on 08 March 2016

What To Expect From This Bear Market Rally

by Michael E. Lewitt

Money Morning Article of the Week

Stocks rallied for the third straight week in what appears to be a classic bear market rally. Investors should count their good luck and use higher prices as an opportunity to reduce equity exposure or hedge stocks they don't want to sell.

Last week the Dow Jones Industrial Average jumped by 367 points or 2.2% to 17,006.77 while the S&P 500 rose by 52 points or 2.7% to 1999.99. The Nasdaq Composite Index rose 2.8% to 4717.02. The major averages have gained about 10% since their February lows, giving investors hope that the worst is over.

I do not believe it is. Despite some moderately positive economic news last week, the global economy remains depressed and the prospects for significantly higher stock prices are low. Let me explain.

Markets were encouraged by what they interpreted as strong economic data as well as signs that the oil price decline may be over. Friday's jobs report, which was weaker than it looked, convinced them that the U.S. is unlikely to fall into recession this year. Earlier in the week, manufacturing data was modestly better than expected. And most important, oil prices rose sharply last week, teasing the end of the energy collapse.

The Fed will Turn Good News into Bad News Again

Let's assume for the sake of argument that they are correct about all of these factors. The problem with such a scenario is that, with a 4.9% unemployment rate and inflation ticking up toward its 2% target, the Federal Reserve is under increasing pressure to raise interest rates. Weak markets gave the Fed an excuse to delay doing so.

But a combination of better economic data and stable/rising markets makes it more likely that the Fed will increase interest rates sooner rather than later. They are unlikely to move this month but the odds of a June hike are increasing. And as we saw after the Fed raised rates in December, markets do not react well to such moves.

Higher rates would mean a stronger dollar, which would place downward pressure on oil prices and corporate earnings in the U.S. The corporate credit markets have already raised the cost of capital for both investment grade and junk bond borrowers, which will further depress corporate earnings.

In other words, the good news that investors celebrated last week could very quickly turn into bad news. And if investors are wrong and the economy is not all that strong (which is what I believe), they are jumping the gun. Either way, stocks look very risky here and investors should proceed accordingly.

The One Stock to Avoid at All Costs

While many stocks regained some of their early 2016 losses over the last three weeks, one stock that has not is Valeant Pharmaceutical International Inc. (NYSE: VRX). In fact, the VRX story keeps getting uglier and uglier and is reflected in the stock reaching new lows this week before closing at $61.31 per share, down from $80.65 a week before.

The stock collapsed (again) this week after the company made a series of announcements - the return of its CEO J. Michael Pearson from a medical leave, the withdrawal of its 2016 earnings guidance and the departure of another key executive responsible for overseeing two of the company's most important drugs.

It also disclosed a new SEC investigation into its relationship with defunct mail order pharmacy Philidor RX Services. Analysts are questioning with good reason the company's ability to service its $31 billion debt load, a concern that was bolstered by Moody's Investors Service placing the debt on watch for a downgrade.

Anyone looking for good news at VRX is looking in the wrong place. A company built on a toxic combination of debt, drug price hikes, low R&D and a refusal to tell investors the truth is now paying the price. Investors should avoid this stock at all costs.

>>>>> Scroll down to view and make comments <<<<<<

Click here for Historical Investing Post Listing










Make a Comment

Econintersect wants your comments, data and opinion on the articles posted.  As the internet is a "war zone" of trolls, hackers and spammers - Econintersect must balance its defences against ease of commenting.  We have joined with Livefyre to manage our comment streams.

To comment, using Livefyre just click the "Sign In" button at the top-left corner of the comment box below. You can create a commenting account using your favorite social network such as Twitter, Facebook, Google+, LinkedIn or Open ID - or open a Livefyre account using your email address.



You can also comment using Facebook directly using he comment block below.





Econintersect Investing


search_box

Print this page or create a PDF file of this page
Print Friendly and PDF


The growing use of ad blocking software is creating a shortfall in covering our fixed expenses. Please consider a donation to Econintersect to allow continuing output of quality and balanced financial and economic news and analysis.


Take a look at what is going on inside of Econintersect.com
Main Home
Analysis Blog
Tax Reform: The Good, the Bad, and the Really Ugly, Part Three
A New Era of Central Banking?
News Blog
17 February 2017: ECRI's WLI Growth Index Again Moderately Declines
Final February 2017 Michigan Consumer Sentiment Inches Up. Better Than Forecast
January 2017 Headline New Home Sales Significantly Improve But Below Expectations
Why The Proposed Border Tax Adjustment Is Unlikely To Promote U.S. Exports
Rail Week Ending 18 February 2017: Improvement Continues
Infographic Of The Day: Cannabis Law: The Past, Present And Future
Early Headlines: Asia Stocks, Dollar And Oil All Slip. Gold Steady, US Oil Exports Surge, Trump Backs Priv. Prisons, WH Hints Pot Crackdown, London Home Prices Slow, Trump Policies Will Help China And More
When Evidence Says No, But Doctors Say Yes
Pacific Rim States Affected By Trump's War On Free Trade
Real Paleo Diet: Early Hominids Ate Just About Everything
Amazon's Global Workforce Is Growing Rapidly
What We Read Today 23 February 2017
February 2017 Kansas City Fed Manufacturing At Highest Level Since June 2011
Investing Blog
Can You Spot Low Risk Entries?
Technical Thoughts: Trading, Luck Or Skill?
Opinion Blog
Fed Up: Culture Shock
Kenneth Arrow's Ignored Impossibility Theorem
Precious Metals Blog
Deflation And Gold: A Contrarian View
Live Markets
24Feb2017 Market Commentary: Wall Street Opened Moderately Lower, Crude Prices Take A Dump, US Dollar Rises Sharply
Amazon Books & More






.... and keep up with economic news using our dynamic economic newspapers with the largest international coverage on the internet
Asia / Pacific
Europe
Middle East / Africa
Americas
USA Government





























 navigate econintersect.com

Blogs

Analysis Blog
News Blog
Investing Blog
Opinion Blog
Precious Metals Blog
Markets Blog
Video of the Day
Weather

Newspapers

Asia / Pacific
Europe
Middle East / Africa
Americas
USA Government
     

RSS Feeds / Social Media

Combined Econintersect Feed
Google+
Facebook
Twitter
Digg

Free Newsletter

Marketplace - Books & More

Economic Forecast

Content Contribution

Contact

About

  Top Economics Site

Investing.com Contributor TalkMarkets Contributor Finance Blogs Free PageRank Checker Active Search Results Google+

This Web Page by Steven Hansen ---- Copyright 2010 - 2017 Econintersect LLC - all rights reserved